An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT_Chinese Journal of Evidence-Based Medicine

Authors：

ZHOU Qi ^1,2,3 , XING Dan ⁴ , LI Qinyuan ⁵ , ZHANG Jingyi ⁶ , LUO Xufei ⁷ , YANG Nan ¹ , WANG Xiaoqin ⁸ , YANG Kehu ¹ , TIAN Jinhui ¹ , LI Hui ⁹ , LI Bo ¹⁰ , CAI Yujia ¹¹ , JIN Yinghui ¹² , LV Lanting ¹³ , SUN Feng ¹⁴ , SHANG Shuxian ¹⁵ , YUAN Beibei ¹⁶ , LI Jiang ¹⁷ , MA Bin ¹ , LI Xiuxia ⁷ , YUAN Yuanzhi ^18,19 , WU Lei ²⁰ , WANG Bin ²¹ , JIANG Lei ²² , WANG Zhiwen ²³ ,  CHEN Yaolong ^1,2,3 , DU Liang ¹¹

1. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
2. Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
3. Institute of Health Data Science, Lanzhou University, Lanzhou 730000, P. R. China;
4. Arthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing 100044, P. R. China;
5. Department of Respiratory Medicine Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, P. R. China;
6. Center for Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou 510317, P. R. China;
7. School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
8. The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton L8S4L8, Canada;
9. Key Research Department of Standardization of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, P. R. China;
10. Beijing Hospital of Traditional Chinese Medicine, Capital Medical University/Beijing Institute of Chinese Medicine/Beijing Evidence-based Chinese Medicine Center, Beijing 100010, P. R. China;
11. Chinese Evidence-based Medicine Centre, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
12. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
13. School of Public Administration and Policy, Health Technology Assessment and Policy Evaluation Group, Renmin University of China, Beijing 100872, P. R. China;
14. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, P. R. China;
15. Editorial Office of Chinese Journal of Dermatology and International Journal of Dermatology and Vernereology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, P. R. China;
16. China Center for Health Development Studies, Peking University, Beijing 100191, P. R. China;
17. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P. R. China;
18. Department of Ophthalmology, Zhongshan Hospital Affiliated to Fudan University; Center for Evidence-based Medicine, Fudan University, Shanghai 200032, P. R. China;
19. Xiamen Branch, Zhongshan Hospital Affiliated to Fudan University, Xiamen 361015, P. R. China;
20. Department of Pulmonary and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, P. R. China;
21. Department of Orthopedic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, P. R. China;
22. Department of General Surgery, the First Hospital of Lanzhou University, Lanzhou 730000, P. R. China;
23. School of Nursing, Peking University, Beijing 100191, P. R. China;

Corresponding?author：

CHEN Yaolong, Email: chenyaolong@lzu.edu.cn

Keywords：

Clinical practice guideline; Guidelines interpretation; Reporting guideline; RIGHT

DOI：

10.7507/1672-2531.202201137

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective The purpose of the extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines (RIGHT for INT) was to promote the development of comprehensive and clear article those introduced and interpreted clinical practice guidelines. Methods The RIGHT for INT checklist was developed following methods recommended by the EQUATOR Network. The development process included three stages. In the first stage, a multidisciplinary team of experts was recruited by email and WeChat and further divided into three groups (a steering group, a consensus group, and a secretariat group); in the second stage, the initial items were collected by literature review and brainstorming; and in the third stage, the final items were formed through a Delphi survey and expert consultation. Results A total of 40 initial items were collected through literature review and brainstorming. A final checklist of 27 items was formed after the Delphi survey and expert consultation. Conclusion The RIGHT for INT checklist provides guidance for guideline interpreters on how to introduce and interpret clinical practice guidelines in a scientific and comprehensive manner.

Citation： ZHOU Qi, XING Dan, LI Qinyuan, ZHANG Jingyi, LUO Xufei, YANG Nan, WANG Xiaoqin, YANG Kehu, TIAN Jinhui, LI Hui, LI Bo, CAI Yujia, JIN Yinghui, LV Lanting, SUN Feng, SHANG Shuxian, YUAN Beibei, LI Jiang, MA Bin, LI Xiuxia, YUAN Yuanzhi, WU Lei, WANG Bin, JIANG Lei, WANG Zhiwen, CHEN Yaolong, DU Liang. An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT. Chinese Journal of Evidence-Based Medicine, 2022, 22(5): 497-507. doi: 10.7507/1672-2531.202201137 Copy

1.	Institute of Medicine (US). Clinical practice guidelines we can trust. Washington (DC): National Academies Press (US), 2011.
2.	Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet, 2003, 362(9391): 1225-1230.
3.	Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines. A framework for improvement. JAMA, 1999, 282(15): 1458-1465.
4.	Tabak RG, Khoong EC, Chambers DA, et al. Bridging research and practice: models for dissemination and implementation research. Am J Prev Med, 2012, 43(3): 337-350.
5.	Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use. A conceptual framework of implementability. Implement Sci, 2011, 6: 26.
6.	Pronovost PJ. Enhancing physicians' use of clinical guidelines. JAMA, 2013, 310(23): 2501-2502.
7.	Cosby JL. Improving patient care: the implementation of change in clinical practice. Qual Saf Health Care. 2006, 15(6): 447.
8.	Yang K, Chen Y, Li Y, et al. Editorial: can China master the guideline challenge. Health Res Policy Syst, 2013, 11: 1.
9.	Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess, 2004, 8(6): iii-iv, 1i-72i.
10.	Medves J, Godfrey C, Turner C, et al. Systematic review of practice guideline dissemination and implementation strategies for healthcare teams and team-based practice. Int J Evid Based Healthc, 2010, 8(2): 79-89.
11.	王夢書, 李樂, 任雨寒, 等. 韓國恰當應用心臟CT檢查指南方法學解讀. 中國循證醫學雜志, 2017, 17(6): 730-735.
12.	王子君, 周奇, 邢丹, 等. 中國臨床實踐指南/共識解讀類文獻報告質量分析. 協和醫學雜志, 2021, 12(2): 260-267.
13.	Chen Y, Yang K, Maru?ic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.
14.	Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med, 2010, 7(2): e1000217.
15.	Alfaro Lara ER, Vega Coca MD, Galván Banqueri M, et al. Selection of tools for reconciliation, compliance and appropriateness of treatment in patients with multiple chronic conditions. Eur J Intern Med, 2012, 23(6): 506-512.
16.	Eubank BH, Mohtadi NG, Lafave MR, et al. Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol, 2016, 16: 56.
17.	Martínez García L, Pardo-Hernandez H, Ni?o de Guzman E, et al. Development of a prioritisation tool for the updating of clinical guideline questions: the UpPriority Tool protocol. BMJ Open, 2017, 7(8): e017226.
18.	何娜, 蘇珊, 翟所迪, 等. 《中國萬古霉素治療藥物監測指南(2020更新版)》解讀. 臨床藥物治療雜志, 2021, 19(1): 12-16.
19.	李龍. 《慢性靜脈疾病硬化療法歐洲指南》解讀. 介入放射學雜志, 2016, 25(9): 743-749.
20.	孫備, 冀亮. 2015年美國胃腸病學會《無癥狀性胰腺囊性腫瘤診治指南》解讀. 中國實用外科雜志, 2015, 35(5): 515-518.
21.	趙軍. 美國《退伍軍人事務部-人事部腦卒中康復治療管理臨床實踐指南》解讀. 中國實用內科雜志, 2013, 33(8): 605-607.
22.	Gershenson S, Polikoff MS, Wang R. When paywall goes AWOL: the demand for open-access education research. Educational Researcher, 2020, 49(4): 254-261.
23.	Squires BP. Structured abstracts of original research and review articles. CMAJ, 1990, 143(7): 619-622.
24.	李萌, 鄧艾平, 王奕. 2014年MASCC/ISOO腫瘤治療繼發黏膜炎管理的臨床實踐指南解讀. 中華放射腫瘤學雜志, 2016, 25(12): 1388-1391.
25.	邢丹, 陳耀龍, 王琪, 等. 《AAOS手術治療膝骨關節炎臨床實踐指南》方法學解讀和推薦建議闡釋. 中國循證醫學雜志, 2018, 18(8): 793-801.
26.	徐虹, 沈茜. 泌尿道感染診治循證指南(2016)解讀. 中華兒科雜志, 2017, 55(12): 902-904.
27.	翟所迪, 賀蓓, 王睿, 等. 《中國萬古霉素治療藥物監測指南》解讀. 中國臨床藥理學雜志, 2016, 32(17): 1633-1636.
28.	邢丹, 陳耀龍, 曾憲濤, 等. 2019年《OARSI非手術治療膝、髖及多關節骨關節炎臨床實踐指南》方法學解讀和推薦意見闡釋. 中國循證醫學雜志, 2020, 20(3): 258-266.
29.	時晶, 倪敬年, 田金洲, 等. 中國癡呆診療指南——輕度認知損害診療指南解讀. 中國醫學前沿雜志(電子版), 2012, (10): 67-70.
30.	Molino CGRC, Leite-Santos NC, Gabriel FC, et al. Factors associated with high-quality guidelines for the pharmacologic management of chronic diseases in primary care: a systematic review. JAMA Intern Med, 2019, 179(4): 553-560.
31.	張遷, 秦天柱, 王琦, 等. 《NutriRECS飲食指南: 未加工紅肉和加工肉類的攝入》解讀. 中國循證醫學雜志, 2021, 21(5): 514-519.
32.	Johnston BC, Zeraatkar D, Han MA, et al. Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the Nutritional Recommendations (NutriRECS) Consortium. Ann Intern Med, 2019, 171(10): 756-764.
33.	王洪燕, 褚曉凌, 郭永建. 英國《成人重癥患者貧血與紅細胞輸血管理指南》之解讀. 中國輸血雜志, 2013, 26(2): 194-200.
34.	李曉強, 段鵬飛, 王深明. 2012版《深靜脈血栓形成的診斷和治療指南》解讀. 中華醫學雜志, 2013, 93(29): 2262-2263.
35.	陳耀龍, 史乾靈, 趙俊強, 等. 從知到行: 跨越指南理論與實踐的鴻溝. 協和醫學雜志, 2020, 11(6): 746-753.
36.	陳耀龍, 王小琴, 王琪, 等. 遵循指南報告規范提升指南報告質量. 中華內科雜志, 2018, 57(3): 168-170.
37.	Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ, 2008, 336(7652): 1049-1051.

1. Institute of Medicine (US). Clinical practice guidelines we can trust. Washington (DC): National Academies Press (US), 2011.
2. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet, 2003, 362(9391): 1225-1230.
3. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines. A framework for improvement. JAMA, 1999, 282(15): 1458-1465.
4. Tabak RG, Khoong EC, Chambers DA, et al. Bridging research and practice: models for dissemination and implementation research. Am J Prev Med, 2012, 43(3): 337-350.
5. Gagliardi AR, Brouwers MC, Palda VA, et al. How can we improve guideline use. A conceptual framework of implementability. Implement Sci, 2011, 6: 26.
6. Pronovost PJ. Enhancing physicians' use of clinical guidelines. JAMA, 2013, 310(23): 2501-2502.
7. Cosby JL. Improving patient care: the implementation of change in clinical practice. Qual Saf Health Care. 2006, 15(6): 447.
8. Yang K, Chen Y, Li Y, et al. Editorial: can China master the guideline challenge. Health Res Policy Syst, 2013, 11: 1.
9. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess, 2004, 8(6): iii-iv, 1i-72i.
10. Medves J, Godfrey C, Turner C, et al. Systematic review of practice guideline dissemination and implementation strategies for healthcare teams and team-based practice. Int J Evid Based Healthc, 2010, 8(2): 79-89.
11. 王夢書, 李樂, 任雨寒, 等. 韓國恰當應用心臟CT檢查指南方法學解讀. 中國循證醫學雜志, 2017, 17(6): 730-735.
12. 王子君, 周奇, 邢丹, 等. 中國臨床實踐指南/共識解讀類文獻報告質量分析. 協和醫學雜志, 2021, 12(2): 260-267.
13. Chen Y, Yang K, Maru?ic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.
14. Moher D, Schulz KF, Simera I, et al. Guidance for developers of health research reporting guidelines. PLoS Med, 2010, 7(2): e1000217.
15. Alfaro Lara ER, Vega Coca MD, Galván Banqueri M, et al. Selection of tools for reconciliation, compliance and appropriateness of treatment in patients with multiple chronic conditions. Eur J Intern Med, 2012, 23(6): 506-512.
16. Eubank BH, Mohtadi NG, Lafave MR, et al. Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology. BMC Med Res Methodol, 2016, 16: 56.
17. Martínez García L, Pardo-Hernandez H, Ni?o de Guzman E, et al. Development of a prioritisation tool for the updating of clinical guideline questions: the UpPriority Tool protocol. BMJ Open, 2017, 7(8): e017226.
18. 何娜, 蘇珊, 翟所迪, 等. 《中國萬古霉素治療藥物監測指南(2020更新版)》解讀. 臨床藥物治療雜志, 2021, 19(1): 12-16.
19. 李龍. 《慢性靜脈疾病硬化療法歐洲指南》解讀. 介入放射學雜志, 2016, 25(9): 743-749.
20. 孫備, 冀亮. 2015年美國胃腸病學會《無癥狀性胰腺囊性腫瘤診治指南》解讀. 中國實用外科雜志, 2015, 35(5): 515-518.
21. 趙軍. 美國《退伍軍人事務部-人事部腦卒中康復治療管理臨床實踐指南》解讀. 中國實用內科雜志, 2013, 33(8): 605-607.
22. Gershenson S, Polikoff MS, Wang R. When paywall goes AWOL: the demand for open-access education research. Educational Researcher, 2020, 49(4): 254-261.
23. Squires BP. Structured abstracts of original research and review articles. CMAJ, 1990, 143(7): 619-622.
24. 李萌, 鄧艾平, 王奕. 2014年MASCC/ISOO腫瘤治療繼發黏膜炎管理的臨床實踐指南解讀. 中華放射腫瘤學雜志, 2016, 25(12): 1388-1391.
25. 邢丹, 陳耀龍, 王琪, 等. 《AAOS手術治療膝骨關節炎臨床實踐指南》方法學解讀和推薦建議闡釋. 中國循證醫學雜志, 2018, 18(8): 793-801.
26. 徐虹, 沈茜. 泌尿道感染診治循證指南(2016)解讀. 中華兒科雜志, 2017, 55(12): 902-904.
27. 翟所迪, 賀蓓, 王睿, 等. 《中國萬古霉素治療藥物監測指南》解讀. 中國臨床藥理學雜志, 2016, 32(17): 1633-1636.
28. 邢丹, 陳耀龍, 曾憲濤, 等. 2019年《OARSI非手術治療膝、髖及多關節骨關節炎臨床實踐指南》方法學解讀和推薦意見闡釋. 中國循證醫學雜志, 2020, 20(3): 258-266.
29. 時晶, 倪敬年, 田金洲, 等. 中國癡呆診療指南——輕度認知損害診療指南解讀. 中國醫學前沿雜志(電子版), 2012, (10): 67-70.
30. Molino CGRC, Leite-Santos NC, Gabriel FC, et al. Factors associated with high-quality guidelines for the pharmacologic management of chronic diseases in primary care: a systematic review. JAMA Intern Med, 2019, 179(4): 553-560.
31. 張遷, 秦天柱, 王琦, 等. 《NutriRECS飲食指南: 未加工紅肉和加工肉類的攝入》解讀. 中國循證醫學雜志, 2021, 21(5): 514-519.
32. Johnston BC, Zeraatkar D, Han MA, et al. Unprocessed red meat and processed meat consumption: dietary guideline recommendations from the Nutritional Recommendations (NutriRECS) Consortium. Ann Intern Med, 2019, 171(10): 756-764.
33. 王洪燕, 褚曉凌, 郭永建. 英國《成人重癥患者貧血與紅細胞輸血管理指南》之解讀. 中國輸血雜志, 2013, 26(2): 194-200.
34. 李曉強, 段鵬飛, 王深明. 2012版《深靜脈血栓形成的診斷和治療指南》解讀. 中華醫學雜志, 2013, 93(29): 2262-2263.
35. 陳耀龍, 史乾靈, 趙俊強, 等. 從知到行: 跨越指南理論與實踐的鴻溝. 協和醫學雜志, 2020, 11(6): 746-753.
36. 陳耀龍, 王小琴, 王琪, 等. 遵循指南報告規范提升指南報告質量. 中華內科雜志, 2018, 57(3): 168-170.
37. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ, 2008, 336(7652): 1049-1051.

Next Article
Reporting guideline for systematic reviews of animal experiments in the field of traditional Chinese medicine

Chinese Journal of Evidence-Based Medicine

An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content